Levetiracetam 250 mg/1 (Levetiracetam TABLET, FILM COATED) 250 mg/1

Levetiracetam 250 mg tablets are an antiepileptic medication used to manage seizures. This film-coated tablet is designed for oral administration and is manufactured by Rising Pharma Holdings, Inc. in the USA.

Strength

250 mg/1

Pack Size

120 TABLET, FILM COATED in 1 BOTTLE (16571-787-12)

Manufacturer / TM Owner

Rising Pharma Holdings, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Levetiracetam is primarily used as an anticonvulsant to control seizures in adults and children. It is often prescribed for partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures. Levetiracetam 250 mg tablets are part of a treatment plan to help manage these conditions effectively.

Side Effects

Common effects of Levetiracetam may include drowsiness, dizziness, and fatigue. Some users might experience headache, nausea, or irritability. These effects can vary from person to person and are not exhaustive.

Precautions & Warnings

Levetiracetam should be handled with care, especially for individuals with a history of mental health issues or kidney problems. It is important to follow the advice of a healthcare provider regarding its use. Always store the medication in a cool, dry place away from children.

Avoid Interactions

Levetiracetam may interact with other medications, including certain antidepressants, antiepileptics, and drugs that affect the central nervous system. It is advisable to consult a healthcare provider before combining Levetiracetam with other treatments.

Frequently Asked Questions

Levetiracetam is used to manage seizures, including partial-onset, myoclonic, and primary generalized tonic-clonic seizures.

Levetiracetam 250 mg tablets are designed for oral administration. Follow the instructions provided by your healthcare provider.

Common side effects may include drowsiness, dizziness, fatigue, headache, nausea, and irritability.

Levetiracetam may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Levetiracetam 250 mg tablets are manufactured by Rising Pharma Holdings, Inc. in the USA.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.